Is low ceruloplasmin (copper-carrying protein) associated with leukopenia (low white blood cell count)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Low Ceruloplasmin and Leukopenia: Association Through Copper Deficiency

Low ceruloplasmin can be associated with low white blood cells when both are manifestations of copper deficiency, which can cause pancytopenia (including leukopenia). 1

Direct Association Through Copper Deficiency

The primary mechanism linking low ceruloplasmin to leukopenia is copper deficiency, which causes both conditions simultaneously:

  • Copper deficiency causes pancytopenia (reduction in all blood cell lines, including white blood cells) and is specifically recognized as a cause of low ceruloplasmin levels. 1
  • This occurs most commonly in patients receiving parenteral nutrition without adequate trace element supplementation. 1
  • The appearance of pancytopenia alongside low ceruloplasmin should prompt immediate evaluation for copper deficiency. 1

Other Conditions With Low Ceruloplasmin

Low ceruloplasmin occurs in several conditions, but not all cause leukopenia:

Wilson's Disease

  • Ceruloplasmin is typically decreased (usually <0.1 g/L), but leukopenia is not a characteristic feature. 1, 2
  • Extremely low levels (<50 mg/L or <5 mg/dL) strongly suggest Wilson's disease. 1
  • However, 10-36% of Wilson's disease patients may have normal ceruloplasmin levels, particularly children and those with hepatic inflammation. 1, 2

Menkes Disease

  • This X-linked disorder of copper transport (ATP7A mutations) presents with both low ceruloplasmin and pancytopenia. 1
  • This represents another copper metabolism disorder where both findings coexist. 1

Other Causes (Without Leukopenia)

  • Protein loss states (renal or enteric): Low ceruloplasmin without hematologic abnormalities. 1
  • Severe end-stage liver disease: Low ceruloplasmin from any etiology, but cytopenias would be from portal hypertension/hypersplenism rather than the low ceruloplasmin itself. 1
  • Aceruloplasminemia: Complete absence of ceruloplasmin due to gene mutations, but these patients exhibit hemosiderosis (iron accumulation), not copper accumulation, and leukopenia is not characteristic. 1

Clinical Approach

When encountering low ceruloplasmin with leukopenia:

  • First, assess for copper deficiency, particularly in patients with:

    • Parenteral nutrition history without trace elements 1
    • Malabsorption syndromes 2
    • History of gastric surgery 1
  • Measure serum copper levels alongside ceruloplasmin to calculate free copper and assess copper status. 3

  • Consider Menkes disease in male infants with developmental delays and characteristic kinky hair. 1

  • Wilson's disease is less likely if leukopenia is the primary hematologic finding, as it typically does not cause isolated leukopenia (though hemolytic anemia can occur in acute presentations). 1

Critical Pitfall

Do not assume low ceruloplasmin automatically means Wilson's disease when leukopenia is present—this combination more strongly suggests copper deficiency requiring copper supplementation rather than copper chelation therapy. 1, 4 Treating presumed Wilson's disease with chelators in a copper-deficient patient would be catastrophic.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Role of Ceruloplasmin in Diagnosing and Treating Wilson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Effect of Decreased Ceruloplasmin on Free Copper Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Low Ceruloplasmin (Hypoceruloplasminemia)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.